Business Context and Reporting Period
This Form 8-K filing by DarioHealth Corp. (DRIO) reports on events occurring on June 7, 2021, with the report dated June 8, 2021. The filing details the completion of the acquisition of PsyInnovations, Inc. (dba wayForward), a behavioral health technology company.
Key Financial Metrics and Transaction Details
The filing focuses on the financial structure of the Merger rather than the Company's ongoing operational revenue or profit metrics for the period.
- Total Merger Consideration: $6.0 million in cash plus up to $24.0 million in common stock.
- Stock Issuance: Approximately 898,500 shares of Common Stock issued at closing, based on a 60-day VWAP of $21.09.
- Earn-out Potential: Up to an additional 237,000 shares (valued at up to $5.0 million) contingent on behavioral health revenue thresholds in 2022.
- Hold-back Provision: $3.0 million of consideration ($2.75 million in stock and $250,000 in cash) is held back for 18 months to secure indemnification obligations.
The filing text does not provide clear values for the Company's current revenue, profit, cash flow, margins, debt, or liquidity positions outside of the transaction specifics.
Material Changes
The primary material change is the expansion of DarioHealth's portfolio through the acquisition of PsyInnovations. This transaction integrates wayForward's behavioral health solutions into DarioHealth's existing digital health platform. The capital structure has changed due to the issuance of approximately 898,500 new shares of common stock.
Outlook, Risks, and Contingencies
Contingencies: A portion of the consideration (up to $5.0 million in stock) is contingent on future performance. The earn-out is payable only if behavioral health revenues from the Company exceed a certain threshold in 2022.
Risks: The transaction includes a hold-back period of 18 months for $3.0 million to cover potential indemnification claims, representing a risk to the immediate liquidity of the acquired entity's sellers and a potential future liability for the Company if claims arise.
Management Commentary: The filing incorporates by reference a press release (Exhibit 99.1) regarding the closing but does not contain detailed management commentary within the text of the 8-K itself.
Investor Verification Checklist
- Verify the exact revenue threshold required to trigger the $5.0 million earn-out payment in 2022.
- Confirm the dilution impact of the 898,500 newly issued shares on existing shareholders.
- Review the attached press release (Exhibit 99.1) for strategic rationale and integration plans not detailed in the 8-K.
- Monitor future filings for the release of the $3.0 million hold-back funds after the 18-month period.